Beijing Beilu Pharmaceutical Co., Ltd (SZSE:300016) Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. (SZSE:002636) for CNY 248 million on February 29, 2024.